Abstract
A number of pharmacologically distinct recognition sites for serotonin (5-hydroxytryptamine; 5-HT) have been identified at serotoninergic synapses of the CNS. Post-synaptically, these 5-HT binding sites have been associated with 5-HT1-like, 5-HT2 and 5-HT3 receptors. In this short overview, however, attention will be restricted to pre-synaptic recognition sites for 5-HT which are involved in the release and neuronal uptake of 5-HT.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abel, M. S., Clody, M. E., Wennogle, L. P. and Meyerson, L. R. (1985). Effect of chronic desmethylimipramine or electroconvulsive shock on selected brain and platelet neurotransmitter recognition sites. Biochem. Pharmacol., 34, 679–683
Barbaccia, M. M., Gandolfi, O., Chuang, D. M. and Costa, E. (1983). Modulation of neuronal serotonin uptake by a putative endogenous ligand of imipramine recognition sites. Proc. Natl. Acad. Sci. U.S.A., 80, 5134–5138
Biassoni, R. and Vaccari, A. (1985). Selective effects of thiol reagent on the binding sites for imipramine and neurotransmitter amine in the brain. Br. J. Pharmacol., 85, 447–456
Cerrito, F. and Raiteri, M. (1979). Serotonin release is modulated by presynaptic autoreceptors. Eur. J. Pharmacol., 57, 427–430
Chaput, Y., de Montigny, C. and Blier, P. (1986). Effects of a selective 5HT reuptake blocker, citalopram, on the sensitivity of 5HT autoreceptors: electrophysiological studies in the rat brain. Naunyn-Schmiedeberg’s Arch. Pharmacol., 333, 342–348
Davis, A. (1984). Temperature-sensitive conformational changes in [3H]imipramine binding sites and the involvement of sulphur-containing bonds. Eur. J. Pharmacol., 102, 341–347
Engel, G., Göthert, M., Hoyer, D., Schlicker, E. and Hillenbrand, K. (1986). Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites. Naunyn-Schmiederberg’s Arch. Pharmacol., 332, 1–7
Galzin, A. M., Moret, C., Verzier, B. and Langer, S. Z. (1985). Interactions between tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors and the presynaptic 5-hydroxytryptamine inhibitory autoreceptors in the rat hypothalamus. J. Pharmacol. Exp. Ther., 235, 200–211
Graham, D. and Langer, S. Z. (1988). The neuronal sodium-dependent serotonin transporter: studies with [3H]imipramine and [3H]paroxetine. In Osborne, N. N. and Hamon, M. (Eds), Neuronal Serotonin, Wiley, Chichester, pp. 367–391
Graham, D., Tahraoui, L. and Langer, S. Z. (1987). Effects of chronic treatments with selective monoamine oxidase inhibitors and specific 5-hydroxytryptamine uptake inhibitors on [3H]paroxetine binding to rat cerebral cortical membranes. Neuropharmacology, 26, 1087–1092
Habert, E., Graham, D., Tahraoui, L., Claustre, Y. and Langer, S. Z. (1985). Characterization of [3H]paroxetine binding to rat cortical membranes. Eur. J. Pharmacol., 118, 107–114
Habert, E., Graham, D. and Langer, S. Z. (1986). Solubilization and characterization of the 5-hydroxytryptamine transporter complex from rat cerebral cortical membranes. Eur. J. Pharmacol., 122, 197–204
Hyttel, J. (1982). Citalopram: pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog. Neuropsychopharmacol. Biol. Psychiat., 6, 277–295
Langer, S. Z. and Moret, C. (1982). Citalopram antagonizes the stimulation by lysergic acid diethylamide of presynaptic inhibitory serotonin autoreceptors in the rat hypothalamus. J. Pharmacol. Exp. Ther., 222, 220–226
Lee, C. M., Javitch, J. A. and Snyder, S. H. (1983). Recognition sites for norepinephrine uptake; regulation by neurotransmitter. Science, 220, 626–629
Nelson, P. J. and Rudnick, G. (1982). The role of chloride ion in platelet serotonin transport. J. Biol. Chem., 257, 6151–6155
Racagni, G., Mocchetti, I., Calderini, G., Battistella, A. and Brunello, N. (1983). Temporal sequence of changes in central noradrenergic system of rat after prolonged antidepressant treatment: receptor densitization and neurotransmitter interactions. Neuropharmacology, 22, 415–424
Raisman, R., Briley, M. S. and Langer, S. Z. (1980). Specific tricyclic antidepressant binding sites in rat brain characterized by high-affinity [3H]imipramine binding. Eur. J. Pharmacol., 61, 373–380
Ross, S. B. (1982). In Osborne, N. N. (Ed.), Biology of Serotonergic Transmission, Wiley, London, pp. 159–195
Scatton, B., Claustre, Y., Graham, D., Dennis, T., Serrano, A., Arbilla, S., Pimoule, C., Schoemaker, H., Bigg, D. and Langer, S. Z. (1988). SL 81.0385, a novel selective and potent serotonin uptake inhibitor. Drug Devel. Res., 12, 29–40
Sneddon, J. M. (1973). Blood platelets as a model for monoamine-containing neurons. Prog. Neurobiol., 1, 153–198
Stahl, S.M. (1977). The human platelet: a diagnostic and research tool for the study of biogenic amines in psychiatric and neurologic disorders. Arch. Gen. Psychiat., 34, 509–516
Thomas, D. R., Nelson, D. R. and Johnson, A. M. (1987). Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor. Psychopharmacology, 93, 193–200
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Copyright information
© 1989 The editors and contributors
About this chapter
Cite this chapter
Langer, S.Z., Graham, D. (1989). Different Recognition Sites for Serotonin: The Neuronal Na+-dependent Transporter and the Release-modulating Autoreceptor. In: Mylecharane, E.J., Angus, J.A., de la Lande, I.S., Humphrey, P.P.A. (eds) Serotonin. Satellite Symposia of the IUPHAR 10th International Congress of Pharmacology. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-10114-6_30
Download citation
DOI: https://doi.org/10.1007/978-1-349-10114-6_30
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-10116-0
Online ISBN: 978-1-349-10114-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)